BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 23986701)

  • 1. Physiological and pharmacological aspects of the vas deferens-an update.
    Koslov DS; Andersson KE
    Front Pharmacol; 2013; 4():101. PubMed ID: 23986701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of the effects of α1-adrenoceptor antagonism and L-type calcium channel blockade on ejaculation and vas deferens and seminal vesicle contractility in vitro.
    de Almeida Kiguti LR; Pupo AS
    J Sex Med; 2012 Jan; 9(1):159-68. PubMed ID: 21810189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P2X2 receptor expression by interstitial cells of Cajal in vas deferens implicated in semen emission.
    Burton LD; Housley GD; Salih SG; Järlebark L; Christie DL; Greenwood D
    Auton Neurosci; 2000 Nov; 84(3):147-61. PubMed ID: 11111847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a functional alpha 1A- (alpha 1C-) adrenoceptor mediating contraction of the rat epididymal vas deferens and an alpha 1B-adrenoceptor mediating contraction of the rat spleen.
    Burt RP; Chapple CR; Marshall I
    Br J Pharmacol; 1995 Jun; 115(3):467-75. PubMed ID: 7582458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the subtypes of alpha 1-adrenoceptor mediating contractions of rat aorta, vas deferens and spleen.
    Aboud R; Shafii M; Docherty JR
    Br J Pharmacol; 1993 May; 109(1):80-7. PubMed ID: 8098642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occupancy of alpha 1-adrenergic receptors and contraction of rat vas deferens.
    Minneman KP; Fox AW; Abel PW
    Mol Pharmacol; 1983 Mar; 23(2):359-68. PubMed ID: 6300645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different subtypes of alpha 1A-adrenoceptor mediating contraction of rat epididymal vas deferens, rat hepatic portal vein and human prostate distinguished by the antagonist RS 17053.
    Marshall I; Burt RP; Green GM; Hussain MB; Chapple CR
    Br J Pharmacol; 1996 Sep; 119(2):407-15. PubMed ID: 8886428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of hypophysectomy on purinergic and noradrenergic contractility of the rat vas deferens.
    Ralevic V; Burnstock G
    J Auton Pharmacol; 1996 Aug; 16(4):191-6. PubMed ID: 8953373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of vasectomy on the autonomic innervation of the human vas deferens.
    Dixon JS; Gilpin CJ; Gilpin SA; Gosling JA; Grant JF
    J Urol; 1987 May; 137(5):1014-6. PubMed ID: 2437328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Spare" alpha 1-adrenergic receptors and the potency of agonists in rat vas deferens.
    Minneman KP; Abel PW
    Mol Pharmacol; 1984 Jan; 25(1):56-63. PubMed ID: 6143249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A1 adenosine receptor modulation of electrically-evoked contractions in the bisected vas deferens and cauda epididymis of the guinea-pig.
    Haynes JM; Alexander SP; Hill SJ
    Br J Pharmacol; 1998 Jul; 124(5):964-70. PubMed ID: 9692782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of smooth muscle contractility by the epithelium in rat vas deferens: role of ATP-induced release of PGE2.
    Ruan YC; Wang Z; Du JY; Zuo WL; Guo JH; Zhang J; Wu ZL; Wong HY; Chung YW; Chan HC; Zhou WL
    J Physiol; 2008 Oct; 586(20):4843-57. PubMed ID: 18755753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial natriuretic factor inhibits adrenergic and purinergic neurotransmission in the rabbit isolated vas deferens.
    Drewett JG; Trachte GJ; Marchand GR
    J Pharmacol Exp Ther; 1989 Jan; 248(1):135-42. PubMed ID: 2536425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of alpha 1-adrenoceptor subtypes in the rat vas deferens: binding and functional studies.
    Ohmura T; Oshita M; Kigoshi S; Muramatsu I
    Br J Pharmacol; 1992 Nov; 107(3):697-704. PubMed ID: 1361871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo study on the effects of alpha1-adrenoceptor antagonists on intraurethral pressure in the prostatic urethra and intraluminal pressure in the vas deferens in male dogs.
    Noguchi Y; Ohtake A; Suzuki M; Sasamata M
    Eur J Pharmacol; 2008 Feb; 580(1-2):256-61. PubMed ID: 18078926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiology of the vas deferens.
    Steers WD
    World J Urol; 1994; 12(5):281-5. PubMed ID: 7532517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further evidence for adrenergic transmission in the human vas deferens.
    Anton PG; McGrath JC
    J Physiol; 1977 Dec; 273(1):45-55. PubMed ID: 23430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of long-term treatment with haloperidol, clozapine and aripiprazole on mice isolated vas deferens.
    Tanyeri MH; Buyukokuroglu ME; Tanyeri P; Mutlu O; Akar FY; Ulak G; Erden BF
    Int Urol Nephrol; 2017 Sep; 49(9):1561-1567. PubMed ID: 28674852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the antidepressant St. John's wort (Hypericum perforatum) on rat and human vas deferens contractility.
    Capasso R; Borrelli F; Montanaro V; Altieri V; Capasso F; Izzo AA
    J Urol; 2005 Jun; 173(6):2194-7. PubMed ID: 15879886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional variation in purinergic and adrenergic responses in isolated vas deferens of rat, rabbit and guinea-pig.
    Sneddon P; Machaly M
    J Auton Pharmacol; 1992 Dec; 12(6):421-8. PubMed ID: 1474107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.